3D Medicines

About

3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.

Minhang,Shanghai,China
501 - 1000
http://www.3dmedcare.com

Highlights

Stock Symbol

hkg:1244

Total Funding Amount

$140M ¥2.45B $251.10M

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $140M
Industries: Biopharma,Biotechnology,Health Care,Pharmaceutical
Founded date: Jan 1, 2010
Number Of Employee: 501 - 1000
Operating Status: Active
Stock Symbol: hkg:1244
Legal Name: 3D Medicines Corporation

3D Medicines, we use individual’s genetic information to prevent, diagnose, and treat cancer. We develop personalized medicines according to target population’s genetic background, to increase efficacy and safety.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$140M ¥2.45B $251.10M

3D Medicines has raised a total of $140M ¥2.45B $251.10M in funding over 2 rounds. Their latest funding was raised on Dec 15, 2022 from a IPO round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 15, 2022	IPO	$251.10M	—	—	—	Detail
Nov 1, 2020	Series D	—	1	—	—	Detail
Oct 19, 2020	Private Equity（PE）	¥1.50B	11	CPE	—	Detail
Oct 9, 2020	Series Unknown	$140M	7	China Capital Management EFung Capital	—	Detail
Jan 6, 2020	Series Unknown	¥280M	6	China Resources Pharmaceutical Industry Investment Fund	—	Detail

Investments

Number of Investments

Number of Lead Investments

2

0

3D Medicines has made 2 investments. Their most recent investment was on Dec 16, 2015, when Motion AI raised $700K.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 16, 2015 Motion AI	Seed	$700K	Artificial Intelligence	—
Apr 1, 2011 Moon Active	Pre-seed	—	Gaming	—

Investors

Number of Lead Investors

Number of Investors

5

23

3D Medicines is funded by 23 investors. CPE and China Capital Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
CPE	Yes	Private Equity（PE）
China Capital Management	Yes	Series Unknown
EFung Capital	Yes	Series Unknown
China Resources Pharmaceutical Industry Investment Fund	Yes	Series Unknown
China Reform Fund Management	Yes	Private Equity（PE）
Innovitalize Capital	—	Series D
China Capital Investment Group	—	Private Equity（PE）
Haier Homecare	—	Private Equity（PE）
Jimin Kexin Pharmaceutical	—	Private Equity（PE）
Lan Shang Capital	—	Private Equity（PE）